Why It Matters: Older Adults Are at Higher Risk. Each year, about 60,000 adults 65 and older are hospitalized with R.S.V. and about 6,000 to 10,000 die from…
FDA’s decision is based on the data from the pivotal Phase 3 clinical trial in approximately 37,000 participants
Each year in the U.S., it is estimated that between 60,000 and 160,000 older. | June 10, 2023
U S FDA Approves ABRYSVO™, Pfizer s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.